Surgery after First-Line Alectinib for (Locally) Advanced ALK-rearranged NSCLC: Pathological Response and Peri-Operative Results
Journal of Thoracic Oncology(2022)
摘要
The role of surgery after 1rst-line alectinib for is largely unexplored. We aimed to describe the pathological features and surgical early-outcomes of patients undergoing salvage surgery in this framework
更多查看译文
关键词
alectinib, lung surgery, ALK-rearrangement
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要